Soliton: A Solid Play On The Tattoo Removal Opportunity In 2020

|
About: Soliton, Inc. (SOLY)
by: Healthcare on the Move
This article is exclusive for subscribers.
Healthcare on the Move
Biotech, healthcare, value, long/short equity
Summary

RAP device is targeting the big cash-pay tattoo removal market.

The company is targeting the limited launch of the RAP device for tattoo removal by mid of 2020.

Investors should consider risks such as business concentration risks, R&D failure risks, and market uncertainty.

Today, we will see why Soliton (SOLY) is a promising pick for 2020.

Company overview

Soliton, Inc. is a pre-revenue stage medical device company focused on the development and commercialization of innovative products